Key Takeaways
- • Cherubic Ventures closed Fund VI at $68.88 million on September 1, 2026, a hard close that brings the firm's total AUM across six funds past $500 million.
- • Solo GP Matt Cheng, based in Taipei, maintains an early-stage AI-native investment mandate spanning infrastructure, developer tools, enterprise, healthcare, and physical AI/robotics sectors.
- • Portfolio companies have already secured more than $500 million in follow-on capital, demonstrating strong investor validation and exit potential for Cherubic's seed-stage bets.
- • Named portfolio holdings include Entire (led by former GitHub CEO Thomas Dohmke), Sudo AI (valued at approximately $2 billion within two years), Patlytics, Max AI, Generation Lab, and therapiAI.
Summary
Cherubic Ventures, a Taipei-based seed-stage venture fund, concluded its sixth fundraising vehicle at $68.88 million on September 1, 2026, marking a significant milestone in the firm's capital deployment strategy. The hard close elevates Cherubic's aggregate assets under management across all six funds to more than $500 million, positioning the firm as a meaningful allocator within the AI-native investment ecosystem.
Solo general partner Matt Cheng continues to direct the fund's strategy toward early-stage artificial intelligence companies, with particular emphasis on infrastructure, developer tools, enterprise applications, healthcare, and physical AI/robotics. The fund size reflects a deliberate structural choice, with the firm noting the significance of the fund denomination aligned with auspicious numerology—a cultural consideration typical of Asia-based allocators.
The velocity of follow-on capital raised by Cherubic's portfolio companies underscores strong market validation of the firm's initial thesis. Portfolio companies have collectively raised more than $500 million in subsequent funding rounds, indicating robust demand from downstream institutional investors and demonstrating that Cherubic's seed-stage selection process has generated material return multiples. Named holdings—including Entire (led by former GitHub CEO Thomas Dohmke), Sudo AI (valued at approximately $2 billion within two years of investment), Patlytics, Max AI, Generation Lab, and therapiAI—represent a concentrated bet on AI infrastructure and applied AI applications across verticals.
The $68.88 million Fund VI close reflects continued LP confidence in Cheng's thematic conviction on AI-native companies at the seed stage, particularly within Asian venture ecosystems where early-stage capital deployment into infrastructure and developer tools remains competitive.
Solo general partner Matt Cheng continues to direct the fund's strategy toward early-stage artificial intelligence companies, with particular emphasis on infrastructure, developer tools, enterprise applications, healthcare, and physical AI/robotics. The fund size reflects a deliberate structural choice, with the firm noting the significance of the fund denomination aligned with auspicious numerology—a cultural consideration typical of Asia-based allocators.
The velocity of follow-on capital raised by Cherubic's portfolio companies underscores strong market validation of the firm's initial thesis. Portfolio companies have collectively raised more than $500 million in subsequent funding rounds, indicating robust demand from downstream institutional investors and demonstrating that Cherubic's seed-stage selection process has generated material return multiples. Named holdings—including Entire (led by former GitHub CEO Thomas Dohmke), Sudo AI (valued at approximately $2 billion within two years of investment), Patlytics, Max AI, Generation Lab, and therapiAI—represent a concentrated bet on AI infrastructure and applied AI applications across verticals.
The $68.88 million Fund VI close reflects continued LP confidence in Cheng's thematic conviction on AI-native companies at the seed stage, particularly within Asian venture ecosystems where early-stage capital deployment into infrastructure and developer tools remains competitive.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.